| Name | XLR11 & Fluoroalkyl Analogs |
|---|
| Formal Name | (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
|---|
| SMILES | FCCCCCN1C=C(C(C2C(C)(C)C2(C)C)=O)C3=C1C=CC=C3 |
|---|
| InChI Key | PXLDPUUMIHVLEC-UHFFFAOYSA-N |
|---|
| InChI Code | InChI=1S/C21H28FNO/c1-20(2)19(21(20,3)4)18(24)16‐14‐23(13‐9‐5‐8‐12-22)17‐11‐7‐6‐10‐15(16)17/h6‐7,10‐11,14,19H,5,8‐9,12‐13H2,1‐4H3 |
|---|
| Description | XLR11 is tetramethylcyclopropylethanoyl indole analog of AM2201 which is a known abused synthetic cannabinoid1,2 and specifically listed in the Synthetic Drug Control Act of 2011.3 It is related to UR‐144 and other structurally similar compounds described in a patent from Abbott Laboratories4 which had been originally developed as CB2 receptor ligands for the treatment of pain. A recent epidemiological report associates acute kidney injury with XLR‐11 exposure.5 The fluoroalkyl analogs of XLR11 are also expected to have similar biological activity to XLR11 and may be substituted to evade detection in crime labs. |
|---|
Status |
Verified |
|---|
| Submitted | 2013-04-30 |
|---|
| Submitted By | Cayman Chemical
Defense Forensic Science Center, United States Army Criminal Investigation Laboratory (USACIL), Forest Park, Georgia |
|---|
| Published | 2013-05-20 |
|---|
| Contact | Paul D. Kennedy, PhD. at Cayman Chemical |
|---|
| Product Details | Link |
|---|
Monograph |
Download the XLR11 & Fluoroalkyl Analogs Monograph |
|---|
|
|
